Evidence-based Complementary and Alternative Medicine · 2012 · 85 citations · 130 references
PharmacyPharmacokineticsPharmacologyBioavailabilityClinical PharmacologyHepatic PharmacokineticsCirrhosisLiver DiseaseLiver Disease Effects On PharmacokineticsMedicinal Plant KnowledgeMedicinal PlantsPharmacokinetics In Liver DiseaseAlternative MedicineAntioxidant MetabolitesChronic Liver Disease BiochemistryChronic Viral HepatitisCurative InterventionCurative TherapyPlacebo-controlled Efficacy AssessmentVedic Period
Complementary and alternative medicine soughts and encompasses a wide range of approaches; its use begun in ancient China at the time of Xia dynasty and in India during the Vedic period, but thanks to its long-lasting curative effect, easy availability, natural way of healing, and poor side-effects it is gaining importance throughout the world in clinical practice. We conducted a review describing the effects and the limits of using herbal products in chronic liver disease, focusing our attention on those most known, such as quercetin or curcumin. We tried to describe their pharmacokinetics, biological properties, and their beneficial effects (as antioxidant role) in metabolic, alcoholic, and viral hepatitis (considering that oxidative stress is the common pathway of chronic liver diseases of different etiology). The main limit of applicability of CAM comes from the lacking of randomized, placebo-controlled clinical trials giving a real proof of efficacy of those products, so that anecdotal success and personal experience are frequently the driving force for acceptance of CAM in the population.
130
Trends in Alternative Medicine Use in the United States, 1990-1997
David M. Eisenberg, Roger B. Davis, Susan L. Ettner et al. · JAMA · 1998 · 6.7K citations
Why Patients Use Alternative Medicine
John A. Astin · JAMA · 1998 · 2.9K citations
Curcumin for chemoprevention of colon cancer
Jeremy J. Johnson, Hasan Mukhtar · Cancer Letters · 2007 · 397 citations
Medicine, Oncology, Pharmacology +9
Prospective study of chemoprevention of hepatocellular carcinoma with sho-saiko-to (TJ-9)
Hiroko Oka, Sukeo Yamamoto, Tetsuo Kuroki et al. · Cancer · 1995 · 271 citations
Medicine, Oncology, Pharmacology +17